Klinik und Poliklinik für Urologie und Kinderurologie
Klinikum / Johannes Gutenberg-Universität Mainz
Kranz, J.; Schultz-Lampel, Daniela; Huesch, Tanja et al.
Continence and pelvic floor centers-Meaningful certification requirements?UROLOGE. Bd. 60. H. 10. 2021 S. 1269-1276
Rahnama'i, Mohammad S.; Marcelissen, Tom; Geavlete, Bogdan et al.
Current Management of Post-radical Prostatectomy Urinary IncontinenceFRONTIERS IN SURGERY. Bd. 8. 2021
Dressler, Franz F.; Dogan, Serkan; Hennig, Martin et al.
Current practice patterns of perioperative cystectomy management in Germany: a questionnaire surveyAKTUELLE UROLOGIE. Bd. 52. H. 01. 2021 S. 82-87
Tsaur, Igor; Thomas, Anita; Juengel, Eva et al.
Deciphering the Molecular Machinery-Influence of sE-Cadherin on Tumorigenic Traits of Prostate Cancer CellsBIOLOGY-BASEL. Bd. 10. H. 10. 2021
Stabile, A.; Mazzone, E.; Barletta, F. et al.
Development and external validation of a novel tool predicting lymph node invasion in patients with prostate cancer detected at targeted-biopsiesEUROPEAN UROLOGY. Bd. 79. 2021 S. S1715-S1716
Struck, Julian P.; Hennig, Martin J. P.; Hupe, Marie C. et al.
Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational SurveyUROLOGIA INTERNATIONALIS. 2021
Huesch, T.; Haferkamp, A.; Thomas, C. et al.
Dreaming of gender equity in urology: An analysis of urological congressesEUROPEAN UROLOGY. Bd. 79. 2021 S. S1363-S1363
Thomas, A.; Stenzel, P.; Tagscherer, K. et al.
Elements of Wnt/beta-catenin signaling pathway as prognostic biomarkers and therapeutic targets in penile squamous cell carcinomaEUROPEAN UROLOGY. Bd. 79. 2021 S. S931-S931
Nestler, Sebastian; Grune, Britta; Schilchegger, Lydia et al.
Evaluation of stone free rates in early versus delayed primary ureteroscopy: time does matterWORLD JOURNAL OF UROLOGY. Bd. 39. H. 3. 2021 S. 909-914
Al-Hogbani, Mofarej; Duguay, Jeremie; Wagner, Daniel-Christoph et al.
Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumorsUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. Bd. 39. H. 5. 2021